SILVER SPRING, Md., Oct. 22, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2013 financial results before market open on Tuesday, October 29...

SILVER SPRING, Md., Sept. 11, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug...

SILVER SPRING, Md., July 25, 2013 /PRNewswire/ --   -- Total Revenues of $280.6 million -- Earnings per Share of $1.60 per Basic Share or $1.52 per Diluted Share -- Earnings Before Non-Cash Charges of...

SILVER SPRING, Md., July 18, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2013 financial results before market open on Thursday, July 25...

SILVER SPRING, Md., April 25, 2013 /PRNewswire/ --Total Revenues of $245.1 millionEarnings per Share of $1.24 per Basic Share or $1.19 per Diluted ShareEarnings Before Non-Cash Charges of $2.76 per Basic Share, or...

SILVER SPRING, Md., April 18, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2013 financial results before market open on Thursday, April 25...

SILVER SPRING, Md., March 25, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it received a second complete response letter from the United States Food and Drug Administration...

SILVER SPRING, Md., Feb. 26, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2012."Our excellent...

SILVER SPRING, Md., Feb. 19, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2012 financial results before market open on Tuesday...

SILVER SPRING, Md., Feb. 14, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug...

SILVER SPRING, Md., Feb. 4, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to an additional $420 million of the company's...

SILVER SPRING, Md., Nov. 1, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2012."It is certainly gratifying to see...